Triglycerides and HDL are often evaluated separately on standard lipid panels. However, they become far more informative when interpreted together.
A pattern of high triglycerides and low HDL cholesterol commonly signals insulin resistance and disrupted fat metabolism. The triglyceride-to-HDL ratio (TG/HDL ratio) brings these two markers together, offering a more clinically meaningful picture of cardiometabolic risk than either marker alone (McLaughlin et al., 2005).
Because of this, the TG/HDL ratio is increasingly used as a simple marker of insulin resistance, metabolic dysfunction, and cardiovascular risk.
Why HDL Falls With Insulin Resistance
HDL levels typically do not fall because the body stops producing HDL. More often, insulin resistance accelerates the breakdown and clearance of HDL particles from the bloodstream.
Excess carbohydrate intake in the setting of insulin resistance can raise blood triglyceride levels. When triglycerides increase, the liver produces more triglyceride-rich particles called very-low-density lipoproteins (VLDL).
These particles circulate through the bloodstream and interact with LDL and HDL particles.
When triglyceride-rich VLDL particles encounter HDL or LDL, triglycerides are transferred into these particles in exchange for cholesterol through the action of cholesteryl ester transfer protein (CETP) (Tall, 1993; Barter et al., 2003).
As a result:
- HDL particles become enriched with triglycerides
- HDL particles lose cholesterol
- HDL becomes structurally unstable
Triglyceride-rich HDL particles are more fragile. As they circulate, hepatic lipase removes triglycerides from these particles, shrinking them and accelerating their breakdown.
The result is lower HDL cholesterol levels, not because HDL production stopped, but because HDL is cleared from the bloodstream more rapidly (Lamarche et al., 1999; Rashid et al., 2003).
Why the TG/HDL Ratio Is More Informative Than HDL or Triglycerides Alone
Triglycerides alone can signal insulin resistance, but when HDL is also low, it often reflects deeper metabolic dysfunction.
When insulin resistance drives triglyceride enrichment of HDL particles, those particles become less effective at performing their core functions:
- Removing excess cholesterol from tissues
- Protecting blood vessels from oxidative stress
- Transporting cholesterol back to the liver for disposal
Importantly, HDL dysfunction can occur even when HDL cholesterol levels are only mildly reduced.
Research suggests that HDL function matters more than HDL quantity for cardiovascular disease risk, and a high TG/HDL ratio often signals impaired HDL function (Khera et al., 2011).
This helps explain why medications designed solely to raise HDL levels have not reduced cardiovascular risk. Increasing HDL numbers without correcting the underlying metabolic dysfunction does not restore healthy HDL function (Barter et al., 2007).
A high TG/HDL ratio also often reflects increased production of triglyceride-rich VLDL particles by the liver, which raises the total number of apoB-containing lipoproteins circulating in the bloodstream.
Similar triglyceride exchange occurs with LDL particles. As triglycerides enter LDL, those particles are remodeled by hepatic lipase, producing smaller, denser LDL particles that are more atherogenic (Austin et al., 1990; Packard, 2006).
This process can occur even when LDL cholesterol levels appear normal on standard lipid panels. For this reason, the TG/HDL ratio can reveal hidden metabolic risk that traditional cholesterol numbers may miss.
What Different TG/HDL Ratios Suggest About Risk
In general, lower TG/HDL ratios reflect better insulin sensitivity and healthier fat metabolism.
TG/HDL < 2
Commonly seen in insulin-sensitive individuals with efficient triglyceride clearance and stable HDL function.
TG/HDL ≈ 2–3
Often signals early or developing insulin resistance, even when fasting glucose and LDL cholesterol remain normal.
TG/HDL ≥ 3–3.5
Associated with:
- Impaired triglyceride clearance
- Dysfunctional HDL particles
- Higher burden of atherogenic lipoproteins
- Increased cardiovascular risk
These patterns often appear years before diabetes or overt dyslipidemia is diagnosed.
How to Improve a High TG/HDL Ratio
For individuals with an elevated TG/HDL ratio, the most important strategy is improving insulin sensitivity and restoring healthy fat metabolism. High triglycerides are often driven by excess hepatic production of triglyceride-rich particles, which is closely linked to refined carbohydrate intake, added sugars, alcohol consumption, and insulin resistance (Reaven, 2005).
Even when calorie intake appears reasonable, poor carbohydrate quality can raise triglycerides and suppress HDL function. Improving carbohydrate quality and timing is often the most effective first step.
Key strategies include:
- Emphasizing minimally processed carbohydrates
- Consuming adequate protein with meals
- Increasing dietary fiber intake
- Reducing added sugars
These changes help stabilize post-meal blood sugar and improve triglyceride clearance (Ter Horst & Serlie, 2017; Giacco et al., 2014). Regular physical activity also plays a critical role. Both aerobic exercise and resistance training improve insulin sensitivity and enhance triglyceride clearance (Kraus et al., 2002; Earnest et al., 2014).
The goal is not to chase a specific HDL number in isolation, but to restore the metabolic conditions that allow lipoproteins to function normally.
When insulin sensitivity improves:
- TG/HDL ratio often improves naturally.
- Triglycerides tend to fall
- HDL stabilizes
Bottom Line
The TG/HDL ratio combines two common lipid markers to provide insight into metabolic health. When triglycerides are high and HDL is low, it often reflects underlying insulin resistance and impaired fat metabolism.
Because these changes affect how lipoproteins function, not just their quantity, the TG/HDL ratio can reveal cardiometabolic risk that standard cholesterol numbers may miss.
In general:
- TG/HDL < 2 suggests healthy triglyceride metabolism
- TG/HDL ~2–3 may signal developing insulin resistance
- TG/HDL ≥3–3.5 is commonly associated with metabolic dysfunction and higher cardiovascular risk
Improving insulin sensitivity through diet quality, fiber intake, and regular physical activity often lowers triglycerides and allows HDL function to recover naturally.
About the Author
Joseph Lehrberg, MS, RD is a registered dietitian specializing in cardiovascular and metabolic health and founder of CardioFunction Integrative Nutrition Services, a nutrition practice based in Boston. He works with patients with elevated cholesterol, high coronary artery calcium scores, high triglycerides, statin intolerance, and other cardiometabolic risk factors to develop evidence-based nutrition strategies for long-term heart health.
Learn more about working with him here.
References
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2005). Use of metabolic markers to identify insulin resistance. Annals of Internal Medicine, 139(10), 802–809.
Lamarche B, Uffelman KD, Carpentier A, Cohn JS, Steiner G, Barrett PH, Lewis GF. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest. 1999 Apr;103(8):1191-9.
Barter, P. J., Brewer, H. B., Chapman, M. J., Hennekens, C. H., Rader, D. J., & Tall, A. R. (2003). Cholesteryl ester transfer protein: A novel target for raising HDL and inhibiting atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(2), 160–167.
Rashid, S., et al. (2003). Hepatic lipase promotes selective uptake of cholesteryl esters from HDL. Journal of Lipid Research, 44(7), 1271–1279.
Khera, A. V., et al. (2011). Cholesterol efflux capacity, HDL function, and atherosclerosis. New England Journal of Medicine, 364(2), 127–135.
Barter, P. J., et al. (2007). Effects of torcetrapib in patients at high risk for coronary events. New England Journal of Medicine, 357(21), 2109–2122.
Packard, C. J. (2006). Triacylglycerol-rich lipoproteins and the generation of small, dense LDL. Biochemical Society Transactions, 34(3), 428–432.
Reaven, G. M. (2005). The insulin resistance syndrome: Definition and dietary approaches. Annual Review of Nutrition, 25, 391–406.
Ter Horst, K. W., & Serlie, M. J. (2017). Dietary sugars and insulin resistance. Journal of Clinical Endocrinology & Metabolism, 102(10), 3634–3640.
Giacco R, Costabile G, Della Pepa G, Anniballi G, Griffo E, Mangione A, Cipriano P, Viscovo D, Clemente G, Landberg R, Pacini G, Rivellese AA, Riccardi G. A whole-grain cereal-based diet lowers postprandial plasma insulin and triglyceride levels in individuals with metabolic syndrome. Nutr Metab Cardiovasc Dis. 2014 Aug;24(8):837-44.
Kraus, W. E., et al. (2002). Effects of the amount and intensity of exercise on plasma lipoproteins. Journal of Applied Physiology, 92(4), 1579–1585.
Earnest, C. P., et al. (2014). Exercise dose and insulin sensitivity: Relevance for cardiovascular risk reduction. Journal of Clinical Lipidology, 8(5), 477–485.
